Cargando…
Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569037/ http://dx.doi.org/10.1186/s12935-022-02744-2 |
| _version_ | 1784809776911220736 |
|---|---|
| author | Sun, Dan Wang, Ying Wang, Huan Xin, Yan |
| author_facet | Sun, Dan Wang, Ying Wang, Huan Xin, Yan |
| author_sort | Sun, Dan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9569037 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95690372022-10-16 Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 Sun, Dan Wang, Ying Wang, Huan Xin, Yan Cancer Cell Int Retraction Note BioMed Central 2022-10-14 /pmc/articles/PMC9569037/ http://dx.doi.org/10.1186/s12935-022-02744-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Sun, Dan Wang, Ying Wang, Huan Xin, Yan Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title | Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title_full | Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title_fullStr | Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title_full_unstemmed | Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title_short | Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 |
| title_sort | retraction note: the novel long non-coding rna lats2-as1-001 inhibits gastric cancer progression by regulating the lats2/yap1 signaling pathway via binding to ezh2 |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569037/ http://dx.doi.org/10.1186/s12935-022-02744-2 |
| work_keys_str_mv | AT sundan retractionnotethenovellongnoncodingrnalats2as1001inhibitsgastriccancerprogressionbyregulatingthelats2yap1signalingpathwayviabindingtoezh2 AT wangying retractionnotethenovellongnoncodingrnalats2as1001inhibitsgastriccancerprogressionbyregulatingthelats2yap1signalingpathwayviabindingtoezh2 AT wanghuan retractionnotethenovellongnoncodingrnalats2as1001inhibitsgastriccancerprogressionbyregulatingthelats2yap1signalingpathwayviabindingtoezh2 AT xinyan retractionnotethenovellongnoncodingrnalats2as1001inhibitsgastriccancerprogressionbyregulatingthelats2yap1signalingpathwayviabindingtoezh2 |